Skip to main content
. 2019 Aug 21;6(10):ofz377. doi: 10.1093/ofid/ofz377

Figure 1.

Figure 1.

Flow-chart of patients failing integrase strand transfer inhibitor (INSTI)-based treatment in South Africa. *, For patients with ≥1 genotype request, only the most recent result was included. ¥, Three of 34 patients had been exposed to raltegravir (RAL) in the past but have no record on INSTI exposure at time of genotyping. ART, antiretroviral treatment; DTG, dolutegravir; EVG, elvitegravir.